AGT and myocardial ischemia: Hence Nr4a1 deletion reduces ECM production in both myocardial ischemia and Ang II models, however, while this is advantageous in a non-ischemic setting (i.e. Ang II), it is detrimental in ischemia where proper scar formation is essential to long-term cardiac function.